Building on the success of the first Handbook of Neuroendocrine Tumours, the second edition of this book has expanded to include thoracic neuroendocrine tumours, as well as covering the many recent advances in epidemiology, the updated WHO classification, and new treatment options. Chapters have been structured to include both European and American perspectives, from the leading world authorities, in order to provide a globally relevant perspective.

The aim of this book is not only to highlight the advances in management, but to demonstrate how those management options can be tailored to the therapy of individual patients based on an understanding of the biology of each individual patient’s tumour.

Chapters:

An overview of thoracic and gastrointestinal neuroendocrine tumours
Martyn Caplin, UK; James C Yao, USA

The changing face of neuroendocrine tumours epidemiology: an analysis of 51 849 cases
Irvin M Modlin, Ben Lawrence, Anthony K Chan, Mark Kidd, USA; Bjorn I Gustafsson, Norway

Classification of neuroendocrine tumours
Guido Rindi, Cesare Bordi, Italy; David S Klimstra, USA

Familial syndromes associated with neuroendocrine tumours
Alain Calender, France; Daniel C Chung, USA

Clinical features of gastroenteropancreatic tumours
Gregory Kaltsas, Greece; Ashley Grossman, UK

Diagnostic pathways
Kjell Oberg, Sweden; David C Metz, USA

Management of the hormonal syndrome of neuroendocrine tumours
Wouter W de Herder, The Netherlands; Tom M O’Dorisio, USA

Oncological management of advanced neuroendocrine tumours
Dermot O’Toole, Philippe Ruszniewski, France; Matthew H Kulke, USA

Surgical management of neuroendocrine tumours: pancreas and intestine
Jeffrey A Norton, USA

Liver metastases: surgical management and liver directed therapies
Eddie K Abdalla, Jula Veerapong, Matthew H G Katz, USA

Surgical management of bronchopulmonary and thymic neuroendocrine tumours
Eric Lim, UK

Treatment algorithms in neuroendocrine tumours of the gastroenteropancreatic system
Bertram Wiedenmann, Ullrich-Frank Pape, Germany

Future treatment prospects
Barbro K Eriksson, Sweden; Matthew H Kulke, USA